Suppr超能文献

阿片肽及其G蛋白偶联受体的结构-功能关系和生理作用

Structure-function relationship and physiological role of apelin and its G protein coupled receptor.

作者信息

Murali Subhashree, Aradhyam Gopala Krishna

机构信息

Department of Biotechnology, Bhupat and Jyoti Mehta School of Biological Sciences, Indian Institute of Technology Madras, Chennai, India.

出版信息

Biophys Rev. 2023 Feb 15;15(1):127-143. doi: 10.1007/s12551-023-01044-x. eCollection 2023 Feb.

Abstract

Apelin receptor (APJR) is a class A peptide (apelin) binding G protein-coupled receptor (GPCR) that plays a significant role in regulating blood pressure, cardiac output, and maintenance of fluid homeostasis. It is activated by a wide range of endogenous peptide isoforms of apelin and elabela. The apelin peptide isoforms contain distinct structural features that aid in ligand recognition and activation of the receptor. Site-directed mutagenesis and structure-based studies have revealed the involvement of extracellular and transmembrane regions of the receptor in binding to the peptide isoforms. The structural features of APJR activation of the receptor as well as mediating G-protein and β-arrestin-mediated signaling are delineated by multiple mutagenesis studies. There is increasing evidence that the structural requirements of APJR to activate G-proteins and β-arrestins are different, leading to biased signaling. APJR also responds to mechanical stimuli in a ligand-independent manner. A multitude of studies has focused on developing both peptide and non-peptide agonists and antagonists specific to APJR. Apelin/elabela-activated APJR orchestrates major signaling pathways such as extracellular signal-regulated kinase (ERKs), protein kinase B (PKB/Akt), and p70S. This review focuses on the structural and functional characteristics of apelin, elabela, APJR, and their interactions involved in the binding and activation of the downstream signaling cascade. We also focus on the diverse signaling profile of APJR and its ligands and their involvement in various physiological systems.

摘要

阿片肽受体(APJR)是一种A类肽(阿片肽)结合G蛋白偶联受体(GPCR),在调节血压、心输出量和维持液体稳态中发挥重要作用。它可被多种内源性阿片肽和埃拉贝拉肽亚型激活。阿片肽亚型具有独特的结构特征,有助于配体识别和受体激活。定点诱变和基于结构的研究表明,受体的细胞外和跨膜区域参与了与肽亚型的结合。通过多项诱变研究阐明了APJR激活受体以及介导G蛋白和β-抑制蛋白介导的信号传导的结构特征。越来越多的证据表明,APJR激活G蛋白和β-抑制蛋白的结构要求不同,导致偏向性信号传导。APJR还以不依赖配体的方式对机械刺激作出反应。众多研究集中于开发针对APJR的肽类和非肽类激动剂及拮抗剂。阿片肽/埃拉贝拉肽激活的APJR协调细胞外信号调节激酶(ERK)、蛋白激酶B(PKB/Akt)和p70S等主要信号通路。本综述重点关注阿片肽、埃拉贝拉肽、APJR的结构和功能特性,以及它们在下游信号级联反应的结合和激活中所涉及的相互作用。我们还重点关注APJR及其配体的多种信号特征以及它们在各种生理系统中的作用。

相似文献

2
Apelin binding to human APJ receptor leads to biased signaling.阿片肽与人类APJ受体结合会导致偏向性信号传导。
Biochim Biophys Acta. 2016 Dec;1864(12):1748-1756. doi: 10.1016/j.bbapap.2016.09.012. Epub 2016 Sep 23.
4
Structural Basis for Apelin Control of the Human Apelin Receptor.阿片肽对人阿片肽受体调控的结构基础
Structure. 2017 Jun 6;25(6):858-866.e4. doi: 10.1016/j.str.2017.04.008. Epub 2017 May 18.
10
A patent review of apelin receptor (APJR) modulators (2014-2019).阿皮林受体(APJR)调节剂的专利研究综述(2014-2019 年)。
Expert Opin Ther Pat. 2020 Apr;30(4):251-261. doi: 10.1080/13543776.2020.1731473. Epub 2020 Feb 20.

引用本文的文献

6
: Turning the page from 2022 to 2023.从2022年翻到2023年。
Biophys Rev. 2023 Feb 23;15(1):1-11. doi: 10.1007/s12551-023-01049-6. eCollection 2023 Feb.
7
Gobind: an inspiring enigma.戈宾德:一个鼓舞人心的谜团。
Biophys Rev. 2023 Feb 13;15(1):71-73. doi: 10.1007/s12551-023-01045-w. eCollection 2023 Feb.

本文引用的文献

7
Advances in therapeutic peptides targeting G protein-coupled receptors.靶向 G 蛋白偶联受体的治疗性肽的研究进展。
Nat Rev Drug Discov. 2020 Jun;19(6):389-413. doi: 10.1038/s41573-020-0062-z. Epub 2020 Mar 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验